Gm. Lew, D-LYSERGIC-ACID REDUCES MICROTUBULE-ASSOCIATED TAU PROTEIN IN SH-SY5YHUMAN NEUROBLASTOMA-CELLS, General pharmacology, 26(5), 1995, pp. 1045-1048
1. SH-SY5Y, an adrenergic human neuroblastoma cell line, was used to e
xamine the hypothesis that D-lysergic acid (LSD) affects the metabolis
m of microtubule-associated tau protein, thus affecting microtubule as
sembly and the transport of neurotransmitters. 2. After 48 hr treatmen
t LSD (10(-5) and 10(-7) M) decreased 50 kDa tau protein in the membra
ne (pellet) fraction. The drug (10(-5) M) also decreased in the cytopl
asmic (supernatant) fraction. 3. This reduction in tau protein was acc
ompanied by a 65% increase (P < 0.05) in total protein after LSD (10(-
7) M) in the cytoplasmic fraction.